Indivior Pharmaceuticals Income Statement (2021-2026) | INDV

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2021 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 221.00M232.00M241.00M253.00M276.00M271.00M293.00M284.00M299.00M307.00M298.00M266.00M302.00M314.00M358.00M317.00M
Cost of Revenue (Quarter) 38.00M40.00M43.00M39.00M50.00M46.00M52.00M38.00M79.00M66.00M50.00M44.00M52.00M83.00M67.00M40.00M
Gross Profit (Quarter) 183.00M192.00M198.00M214.00M226.00M225.00M241.00M246.00M220.00M241.00M248.00M221.00M250.00M230.00M292.00M277.00M
Operating items
Amortization - Intangibles (Quarter) -2.00M-3.00M
Research & Development (Quarter) -14.00M-20.00M-29.00M-27.00M-32.00M-18.00M-30.00M28.00M26.00M22.00M-38.00M22.00M21.00M33.00M21.00M16.00M
Share-based Compensation (IS) (Quarter) 5.00M4.00M5.00M6.00M5.00M6.00M5.00M6.00M7.00M6.00M
Selling, General & Administrative (Quarter) -109.00M-115.00M-431.00M-131.00M-133.00M-390.00M-157.00M143.00M152.00M142.00M175.00M133.00M158.00M155.00M189.00M124.00M
Restructuring Costs (Quarter) -4.00M
Other Operating Expenses (Quarter) 5.00M-1.00M-299.00M6.00M-160.00M-36.00M1.00M-1.00M-2.00M-1.00M
Operating Expenses (Quarter) -123.00M-135.00M-460.00M-158.00M-169.00M-408.00M-187.00M171.00M338.00M206.00M205.00M156.00M178.00M187.00M-487.00M139.00M
Operating Income (Quarter) 63.00M56.00M-258.00M57.00M61.00M-183.00M60.00M65.00M-118.00M35.00M46.00M66.00M72.00M43.00M81.00M137.00M
EBIT (Quarter) 63.00M56.00M-258.00M57.00M61.00M-183.00M60.00M65.00M-118.00M35.00M46.00M66.00M72.00M43.00M81.00M137.00M
Non-operating items
Non Operating Investment Income (Quarter) 1.00M-1.00M3.00M
Interest & Investment Income (Quarter) 2.00M6.00M10.00M11.00M11.00M12.00M10.00M7.00M6.00M5.00M5.00M4.00M6.00M6.00M6.00M3.00M
Other Non Operating Income (Quarter) 1.00M-18.00M
Non Operating Income (Quarter) -5.00M-2.00M2.00M1.00M1.00M2.00M1.00M-2.00M-3.00M-5.00M-9.00M
Net income details
EBT (Quarter) 58.00M54.00M-256.00M58.00M62.00M-181.00M61.00M73.00M-121.00M30.00M38.00M59.00M62.00M37.00M81.00M115.00M
Tax Provisions (Quarter) -10.00M-13.00M73.00M-14.00M-23.00M46.00M-7.00M11.00M-23.00M8.00M17.00M11.00M44.00M-5.00M-21.00M26.00M
Profit After Tax (Quarter) 48.00M41.00M-183.00M44.00M39.00M-135.00M54.00M61.00M-97.00M22.00M21.00M47.00M18.00M42.00M102.00M89.00M
Income from Continuing Operations (Quarter) 68.00M67.00M-329.00M72.00M85.00M-227.00M68.00M62.00M-98.00M22.00M21.00M48.00M18.00M42.00M102.00M89.00M
Consolidated Net Income (Quarter) 68.00M67.00M-329.00M72.00M85.00M-227.00M68.00M62.00M-98.00M22.00M21.00M48.00M18.00M42.00M102.00M89.00M
Income towards Parent Company (Quarter) 68.00M67.00M-329.00M72.00M85.00M-227.00M68.00M62.00M-98.00M22.00M21.00M48.00M18.00M42.00M102.00M89.00M
Net Income towards Common Stockholders (Quarter) 68.00M67.00M-329.00M72.00M85.00M-227.00M68.00M62.00M-98.00M22.00M21.00M48.00M18.00M42.00M102.00M89.00M
Additional items
EPS (Basic) (Quarter) 0.11M0.07M-2.370.23M0.14M-0.23M0.500.45-0.720.160.160.380.150.340.810.71
EPS (Weighted Average and Diluted) (Quarter) 0.11M0.08M-2.370.23M0.14M-0.23M0.500.45-0.720.160.160.380.140.330.790.69
Shares Outstanding (Weighted Average) (Quarter) 70.00M630.00930.00139.00M320.00610.00980.00137.00M136.00M67.00M65.00M132.00M124.00M125.00M125.00M125.00M124.00M
Shares Outstanding (Diluted Average) (Quarter) 610.00890.00139.00M310.00590.00980.00137.00M137.00M790.00420.00133.00M125.00M126.00M129.00M128.00M129.00M
EBITDA (Quarter) 63.00M56.00M-258.00M57.00M61.00M-183.00M60.00M59.00M-97.00M35.00M46.00M49.00M20.00M43.00M81.00M137.00M
Interest Expenses (Quarter) -7.00M-8.00M-8.00M-10.00M-10.00M-10.00M-9.00M9.00M9.00M11.00M-14.00M12.00M15.00M12.00M6.00M7.00M
Tax Rate (Quarter) -17.24%-24.07%-28.52%-24.14%-37.10%-25.41%-11.48%15.07%19.01%26.67%44.74%18.64%70.97%-13.51%-25.93%22.61%